Emily Sander – Lymphoma Cancer Survivor

Emily Sander – Lymphoma Cancer Survivor

VIDEO (Part 3 of 4): Medical Marijuana 411 interview with Emily Sander, student and lymphoma cancer survivor talks about how she utilized medical marijuana as a positive part of her treatment.

Currently, lymphoma free, Emily talks about the benefits of medical marijuana as part of her treatment regimen. A non drug user all of her life, Emily turned to the medicinal use of marijuana to counter the side effects of her chemotherapy.

Transcript of video:

I don’t use medical marijuana to get high. I don’t really drink. I don’t sort of have that “I want to get high” kind of thing.

I’m using it to make myself feel better. Just like (when) someone uses a normal medicine. And just like other people abuse normal medicines.

Its in the same category, if you’re going to abuse it; you’re not using it as a medicine anymore.

So that’s why I feel it should be in the same category as Oxycontin or anything else that someone else could abuse and make it into a drug or use normally and be a benefit on a everyday basis.

This Video is Part 3 of 4

 

Share This Post
  • Marijuana Topicals Drug Tests

    Will Marijuana Topicals Fail A Drug Test?

    2016-10-21
    What Are Marijuana Topicals? Marijuana topicals are cannabis-infused oils lotions or balms, that are absorbed through the skin. They work for soreness, inflammation and pain relief in specific areas. Topicals…
  • medical marijuana for asthma sufferers

    Medical Marijuana For Asthma

    2015-07-08
    [vc_row][vc_column][vc_column_text]Asthma is a condition where airways narrow and swell, and produce extra mucus. This can make breathing very difficult and trigger coughing, wheezing and shortness of breath. Asthma is a…
  • Can Medical Marijuana Help Overcome Opiate Withdrawal Symptoms

    Cannabis drug shows promise in treating schizophrenia

    2015-09-21
    An experimental cannabis drug for treating schizophrenia, developed by UK-based GW Pharmaceuticals Plc, was found to be superior to a placebo in a mid-stage trial. The company's UK-listed shares jumped…